Thrombolysis - What more does it take?

被引:10
作者
Kaste, M [1 ]
机构
[1] Univ Helsinki, Cent Hosp, Dept Neurol, FI-00029 Helsinki, Finland
关键词
D O I
10.1161/01.STR.0000153058.54341.72
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:200 / 202
页数:3
相关论文
共 21 条
[1]   The Mannheim Declaration of Stroke in Eastern Europe - Accepted at the 13th European Stroke Conference, Mannheim-Heidelberg, Germany, May 12-15, 2004 [J].
Bogousslavsky, J ;
Hennerici, MG ;
Kaste, M ;
Csiba, L ;
Brainin, M ;
Gugging, M ;
Bereczki, D ;
Nagy, Z ;
Czlonkowska, A ;
Demarin, V ;
Pascu, J ;
Skvortsova, VI ;
Ehler, E .
CEREBROVASCULAR DISEASES, 2004, 18 (03) :248-248
[2]  
Caplan Louis R, 2004, Rev Neurol Dis, V1, P16
[3]   Tissue plasminogen activator for acute ischemic stroke in clinical practice - A meta-analysis of safety data [J].
Graham, GD .
STROKE, 2003, 34 (12) :2847-2850
[4]   The Desmoteplase In Acute Ischemic Stroke Trial (DIAS) - A phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase [J].
Hacke, W ;
Albers, G ;
Al-Rawi, Y ;
Bogousslavsky, J ;
Davalos, A ;
Eliasziw, M ;
Fischer, M ;
Furlan, A ;
Kaste, M ;
Lees, KR ;
Soehngen, M ;
Warach, S .
STROKE, 2005, 36 (01) :66-73
[5]   Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) [J].
Hacke, W ;
Kaste, M ;
Fieschi, C ;
von Kummer, R ;
Davalos, A ;
Meier, D ;
Larrue, V ;
Bluhmki, E ;
Davis, S ;
Donnan, G ;
Schneider, D ;
Diez-Tejedor, E ;
Trouillas, P .
LANCET, 1998, 352 (9136) :1245-1251
[6]  
HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017
[7]  
Hacke W, 2004, LANCET, V363, P768
[8]   Predictors of in-hospital mortality in patients with acute ischemic stroke treated with thrombolytic therapy [J].
Heuschmann, PU ;
Kolominsky-Rabas, PL ;
Roether, J ;
Misselwitz, B ;
Lowitzsch, K ;
Heidrich, J ;
Hermanek, P ;
Leffmann, C ;
Sitzer, M ;
Biegler, M ;
Buecker-Nott, HJ ;
Berger, K .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (15) :1831-1838
[9]   Findings from the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial [J].
Ingall, TJ ;
O'Fallon, WM ;
Asplund, K ;
Goldfrank, LR ;
Hertzberg, VS ;
Louis, TA ;
Christianson, TJH .
STROKE, 2004, 35 (10) :2418-2424
[10]   A systematic review of barriers to delivery of thrombolysis for acute stroke [J].
Kwan, J ;
Hand, P ;
Sandercock, P .
AGE AND AGEING, 2004, 33 (02) :116-121